type-1

Documents about type-1

• The Ultimate Evolution of Intelligence: From Type 1 to Cosmic Consciousness#98068PhilArchive
• Bigfoot Biomedical Clinical Research Center (CRC) Trial#126007ClinicalTrials.gov
• PETS-D (Parent Education Thru Simulation-Diabetes)#154813ClinicalTrials.gov
• Diabetes Autoimmunity Study in the Young#162376ClinicalTrials.gov
• Effect of GLP-1 on Angiogenesis#184819ClinicalTrials.gov
• Continuous Glucose Monitoring System (CGM)-Informed Bolus Calculator Study#230325ClinicalTrials.gov
• Bilateral Bailey Lattices and Andrews-Gordon Type Identities#344561HAL (France)
• Response to BNT162b2 Vaccine in Adolescents With Type 1 Diabetes#356524ClinicalTrials.gov
• Insulin Sensitivity, Impaired Counterregulation, and Glucose Variability#377350ClinicalTrials.gov
• Sensibilisation au vieillissement des piles à combustible de type PEM#388017HAL (France)
• Looping Whilst Restricting Carbohydrates#417477ClinicalTrials.gov
• Adaptive Biobehavioral Control (ABC) in a Closed-Loop System#422392ClinicalTrials.gov
• Performance Study of the SOLO 2.0 Insulin Pump#426737ClinicalTrials.gov
• Faster Aspart on Insulin-pump Treated T1DM Patients#429693ClinicalTrials.gov
• Skeletal Fragility in Type 1 Diabetes: Glycemic Control and Bone Strength#435690ClinicalTrials.gov
• Safety Study to Assess Whether Proinsulin Peptide Injections Can Slow or Stop the Body Damaging Its Own Insulin-making Cells in the Pancreas in Patients Newly Diagnosed With Type 1 Diabetes#121265ClinicalTrials.gov
• Vey Low-Energy Ketogenic Therapy in Adults With Type 1 Diabetes and Obesity on Intensive Insulin Therapy Using Advanded Hybrid Closed Loop System#272303ClinicalTrials.gov
• Comparison of the Use of Energy Substrates and Hormonal Regulation of Blood Sugar During Exercise of Increasing Intensity Between Children With Type 1 Diabetes and Non-diabetic Control Children.#321643ClinicalTrials.gov
• GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Pioglitazone#18529ClinicalTrials.gov
• GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin#230380ClinicalTrials.gov
• Molecular prevalence of equine herpesvirus type 1 and equine herpesvirus type 4 in Thoroughbred and Arab facilities in Türkiye#252759AVESIS
• EkiYou-Study-2 : A National Multicentric Trial of the EkiYou Application for Insulin Bolus Calculation#253172ClinicalTrials.gov
• GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Sulfonylurea#300424ClinicalTrials.gov
• Hypoglycaemia Was Not Associated With Depression, Anxiety, Diabetes Distress or Fear of Hypoglycaemia Scores in People With Type 1 or Insulin‐Treated Type 2 Diabetes in the Hypo‐ METRICS Study#330068HAL (France)
• HpaP modulates type III effector secretion in Ralstonia solanacearum and harbours a substrate specificity switch domain essential for virulence#156373HAL (France)
• Reliable discrimination of type 1 and type 2 diabetes by flow-through leukocyte-endothelium interactions exploiting advanced hydrodynamic detection parameters.#1342NCBI PubMed Central
• GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin#154863ClinicalTrials.gov
• Effects of Intensive Bolus Intravenous Insulin Delivery on Metabolic Integrity in Type 1 and Type 2 Diabetes#201720ClinicalTrials.gov
• A Study to Assess 11 Beta-hydroxysteroid Dehydrogenase Type 1 Inhibition in Adipose Tissue by SPI-62#217174ClinicalTrials.gov
• Collagen Scaffolds Loaded With HUCMSCs for the Improvement of Erectile Function in Men With Diabetes#272297ClinicalTrials.gov
• GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes#398252ClinicalTrials.gov
• FAMS-T1D Self-Regulation and Social Support for T1D#136252ClinicalTrials.gov
• Supporting Treatment Adherence Needs in Diabetes#160253ClinicalTrials.gov
• Pediatrics Owning Performance Study#175063ClinicalTrials.gov
• Protection Against Pneumococcal Infection in Children With T1DM#208260ClinicalTrials.gov
• Molecular basis of type VI secretion system effector loading#274233HAL (France)
• PeRsOnalising Treatment Of Diabetic Nephropathy:#300379ClinicalTrials.gov
• Outpatient Control-to-Range: System and Monitoring Testing#300403ClinicalTrials.gov
• Cooperation of Insulin and GLP-1 on Myocardial Glucose Uptake#303706ClinicalTrials.gov
• Diabetic Kidney Alarm (DKA) Study#329444ClinicalTrials.gov
• Pharmacology of Insulin Injected With Jet-Injection#329465ClinicalTrials.gov
• Triple Therapy in T1DM#346860ClinicalTrials.gov
• Integrating Omics into Functional Biomarkers of Type 1 Diabetes#360969PubMed Central
• Physiologic Response to Glucagon at Varying Insulin Levels#369943ClinicalTrials.gov
• The T1D Talks Pilot Study#377356ClinicalTrials.gov
• Subject-Conditioned Glucose Forecasting in Type-1 Diabetes#386894arXiv CS
• Fat-induced Release of GLP-1 in Humans#391040ClinicalTrials.gov
• MGA031, Sirolimus and Tacrolimus in Islet Transplantation#391056ClinicalTrials.gov
• Overcoming Barriers and Obstacles to Adopting Diabetes Devices (ONBOARD) Trial#405276ClinicalTrials.gov
• Acceleration of Insulin Action by Hyaluronidase During Closed-Loop Therapy#417483ClinicalTrials.gov